Information  X 
Enter a valid email address

Sopheon PLC (SPE)

  Print          Annual reports

Tuesday 31 August, 2021

Sopheon PLC

Director Shareholdings

RNS Number : 2935K
Sopheon PLC
31 August 2021
 

For immediate release

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

PDMR SHAREHOLDINGS

 

The Company has been notified that Stuart Silcock, a non-executive director of the Company, has sold 74,328 ordinary shares of 20 pence each ("Shares") in the capital of the Company at a price of £9.63 per Share, pursuant to investor demand following the Company's recent results.

 

Mr Silcock has also sold 5,000 Shares held in his dealing account as bare trustee for his grandchildren into his Self-Invested Personal Pension ("SIPP") and has sold 1,000 Shares from his SIPP to the Individual Savings Account ("ISA") of his spouse, Christine Silcock. Mrs Silcock has in turn sold 1,450 shares held in her dealing account to her ISA.

 

Stuart Silcock's total beneficial interest in Ordinary Shares, including those held by his spouse or held on trust for family members, is now 279,490 Ordinary Shares.

 

For further information contact:

Andy Michuda (Executive Chairman)
Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)

Alice Lane (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com .  

 



 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stuart Silcock and Christine Silcock

2. 

Reason for the Notification

a)

Position/status

Director/PDMR and PCA

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Sale of shares

Transfers to SIPP and spouse

Identification code

GB00BSZM1369

b)

Nature of the transaction

Transfer of Shares

c)

Price(s) and volume(s)

Stuart Silcock

Sale Price(s)

Volume(s)

963p

74,328

 

Stuart Silcock & Christine Silcock

Sale Price(s)

Volume(s)

963p

7,450

 

 

d)

Aggregated information:

· Aggregated volume

· Price

As above

e)

Date of the transaction

31 August 2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDUFWFEFSESA

a d v e r t i s e m e n t